{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T18:30:40Z","timestamp":1759602640127},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,5,24]],"date-time":"2010-05-24T00:00:00Z","timestamp":1274659200000},"content-version":"vor","delay-in-days":3644,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objective:<\/jats:bold> The association of transforming growth factor\u2010\u03b21 (TGF\u2010\u03b21) with a matrix metalloproteinase (MMP) and a tissue inhibitor of metalloproteinase (TIMP), as well as myometrial invasion of endometrial cancer was studied.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The effects of TGF\u2010\u03b21 on cellular invasiveness, gelatinase activity, and expression of TIMP\u20101 were examined in 2 endometrial adenocarcinoma cell lines, KLE and Ishikawa. Plasma was obtained from 8 endometrial cancer patients with Stage\u2010Ia disease, from 6 with Stage\u2010Ib disease, and from 4 with Stage\u2010Ic disease, and the levels of TGF\u2010\u03b21 were measured by enzyme immunoassays. The immunohistochemical expression of MMP\u20109, TIMP\u20101, TGF\u2010\u03b21, and TGF\u2010\u03b2 receptor Type I in tumor tissue from the same patients also was detected.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Invasiveness, gelatinase activity, and the expression of TIMP\u20101 were higher in KLE cells than in Ishikawa cells, and they were increased by treatment with rTGF\u2010\u03b21. The expression of TGF\u2010\u03b2 receptor Type I was higher in KLE cells than in Ishikawa cells, which were unresponsive to exogenous TGF\u2010\u03b21. The plasma levels of TGF\u2010\u03b21 were greater in Stage\u2010Ib and Stage\u2010Ic patients than in Stage\u2010Ia patients. MMP\u20109 and TGF\u2010\u03b2 receptor Type I were expressed mainly in tumor cells, while TIMP\u20101 and TGF\u2010\u03b21 were localized in both tumor epithelial cells and stromal cells. MMP\u20109 and TIMP\u20101 were expressed only in Stage\u2010Ib and Stage\u2010Ic patients, although TGF\u2010\u03b21 and TGF\u2010\u03b2 receptor Type I were ubiquitous.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Myometrial invasion of endometrial cancers involves an increase in gelatinase activity, regulated to some extent by TGF\u2010\u03b21 in an autocrine or paracrine fashion.<\/jats:p>","DOI":"10.1111\/j.1447-0756.2000.tb01305.x","type":"journal-article","created":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T20:48:47Z","timestamp":1274906927000},"page":"163-170","source":"Crossref","is-referenced-by-count":19,"title":["The Association of Transforming Growth Factor\u2010\u03b21 with Myometrial Invasion of Endometrial Carcinomas through Effects on Matrix Metalloproteinase"],"prefix":"10.1111","volume":"26","author":[{"given":"Hiromitsu","family":"Yabushita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Narumiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanji","family":"Hiratake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidefumi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuma","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Sawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,5,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0168-9525(90)90126-Q","article-title":"Metalloproteinases and their inhibitors in matrix remodelling","volume":"6","author":"Matrisan LM.","year":"1990","journal-title":"Trends Genet"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1993.207"},{"key":"e_1_2_1_4_2","first-page":"5365","article-title":"Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion","volume":"53","author":"Davies B.","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910580110"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.1997.tb00822.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.30"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/S0021-9258(18)94267-5","article-title":"Independent regulation of collagenase. 72 kDa progelatinase and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor\u2010\u03b2","volume":"264","author":"Overall CM","year":"1989","journal-title":"J Biol Chem"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.10.4577"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1988.135"},{"key":"e_1_2_1_11_2","first-page":"1103","article-title":"Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors","volume":"37","author":"Nishida M.","year":"1985","journal-title":"Acta Obst Gynaec Jpn"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(84)90080-5"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7292(89)90482-7"},{"key":"e_1_2_1_14_2","first-page":"3239","article-title":"A rapid in vitro assay for quantitating the invasive potential of tumor cells","volume":"47","author":"Albini A.","year":"1987","journal-title":"Cancer Res"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(80)90338-3"},{"key":"e_1_2_1_16_2","first-page":"597","article-title":"Some recent advances in the chemistry and biology of transforming growth factor\u2010\u03b2","volume":"195","author":"Sporn MB","year":"1987","journal-title":"J Cell Biol"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.1989.03430070086036","article-title":"Transforming growth factor\u2010\u03b2: Multiple actions and potential clinical applications","volume":"262","author":"Sporn MB","year":"1989","journal-title":"JAMA"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.19.7678"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1993.tb02017.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.7.523"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.280"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1997.tb00360.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01612665"},{"key":"e_1_2_1_24_2","first-page":"636","article-title":"Tumor invasion and the extracellular matrix","volume":"49","author":"Liotta LA","year":"1983","journal-title":"Lab Invest"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.105.2.957"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910540523"},{"key":"e_1_2_1_27_2","first-page":"5476","article-title":"Transforming growth factor gene expression in human endometrial adenocarcinoma cells: Regulation by progestins","volume":"51","author":"Gong Y.","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_1_28_2","first-page":"1704","article-title":"Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells","volume":"52","author":"Gong Y.","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_1_29_2","first-page":"44","article-title":"Genetic change in transforming growth factor \u03b2 (TGF\u2010\u03b2) receptor type I gene correlates with insensitivity to TGF\u2010\u03b21 in human prostate cancer cells","volume":"56","author":"Kim IY","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"26449","DOI":"10.1016\/S0021-9258(18)47215-8","article-title":"Expression of transforming growth factor \u03b2 type II receptor leads to reduced malignancy in human breast cancer MCF\u20107 cells","volume":"269","author":"Sun L.","year":"1994","journal-title":"J Biol Chem"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1447-0756.2000.tb01305.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1447-0756.2000.tb01305.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:20:18Z","timestamp":1698578418000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1447-0756.2000.tb01305.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1111\/j.1447-0756.2000.tb01305.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1447-0756.2000.tb01305.x","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}